{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "new",
                "@type": "core",
                "@stage": "S200"
            },
            "ait:date-delivered": {
                "@day": "10",
                "@timestamp": "2023-09-10T01:59:36.000036-04:00",
                "@year": "2023",
                "@month": "09"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2023",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {
                    "xocs:funding-agency-matched-string": "Genentech",
                    "xocs:funding-agency": "Genentech",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004328",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Takeda",
                    "xocs:funding-agency-acronym": "TPUSA",
                    "xocs:funding-agency": "Takeda Pharmaceuticals U.S.A.",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100007723",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2023-09-10T05:51:45.807Z",
            "xocs:funding-text": "RF Sidonio has acted as a paid consultant to Bayer, Takeda, Octapharma, Genentech, Sanofi, Sobi, Novo Nordisk, Tremeau Pharmaceuticals, Guardian Therapeutics, Uniqure, BioMarin, and Spark. He has received investigator-initiated research funding from Takeda, Octapharma, and Genentech.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60000928",
                            "@country": "usa",
                            "city": "Atlanta",
                            "organization": [
                                {"$": "Aflac Cancer and Blood Disorders Center"},
                                {"$": "Emory University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60000928"},
                                {"@afid": "60032068"}
                            ],
                            "state": "GA",
                            "@affiliation-instance-id": "OB2BibRecID-950575767-485f29d6d271f152e2efd5205cfc44ab-1",
                            "ce:source-text": "Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA, USA"
                        },
                        "author": [{
                            "ce:given-name": "Robert F.",
                            "preferred-name": {
                                "ce:given-name": "Robert F.",
                                "ce:initials": "R.F.",
                                "ce:surname": "Sidonio",
                                "ce:indexed-name": "Sidonio R.F."
                            },
                            "@author-instance-id": "OB2BibRecID-950575767-aa0c47f5040b732e96c930d53921d10e-1",
                            "@seq": "1",
                            "ce:initials": "R.F.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sidonio",
                            "@auid": "6505569713",
                            "ce:suffix": "Jr.",
                            "ce:indexed-name": "Sidonio R.F."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60017031",
                            "@country": "usa",
                            "city": "Chicago",
                            "organization": [
                                {"$": "Division of Hematology"},
                                {"$": "Ann & Robert H. Lurie Children\u2019s Hospital of Chicago"}
                            ],
                            "affiliation-id": {
                                "@afid": "60017031",
                                "@dptid": "113172625"
                            },
                            "state": "IL",
                            "@affiliation-instance-id": "OB2BibRecID-950575767-9eeed83b65254a0f79a88e63dc5b3c7f-1",
                            "ce:source-text": "Division of Hematology, Ann & Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, IL, USA",
                            "@dptid": "113172625"
                        },
                        "author": [{
                            "ce:given-name": "Alexis A.",
                            "preferred-name": {
                                "ce:given-name": "Alexis A.",
                                "ce:initials": "A.A.",
                                "ce:surname": "Thompson",
                                "ce:indexed-name": "Thompson A.A."
                            },
                            "@author-instance-id": "OB2BibRecID-950575767-e82b8385eda849e3cc2aef635c8eaaae-1",
                            "@seq": "2",
                            "ce:initials": "A.A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Thompson",
                            "@auid": "7404597483",
                            "ce:indexed-name": "Thompson A.A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Italy",
                            "@afid": "60007067",
                            "@country": "ita",
                            "city": "Milan",
                            "organization": [
                                {"$": "Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico"},
                                {"$": "Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre and Fondazione Luigi Villa"}
                            ],
                            "affiliation-id": {"@afid": "60007067"},
                            "@affiliation-instance-id": "OB2BibRecID-950575767-0394b20ba66350a8ae964b3d44af924f-1",
                            "ce:source-text": "Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre and Fondazione Luigi Villa, Milan, Italy"
                        },
                        "author": [{
                            "ce:given-name": "Flora",
                            "preferred-name": {
                                "ce:given-name": "Flora",
                                "ce:initials": "F.",
                                "ce:surname": "Peyvandi",
                                "ce:indexed-name": "Peyvandi F."
                            },
                            "@author-instance-id": "OB2BibRecID-950575767-c1d8a516a36013d6f9dbf7149953b20e-1",
                            "@seq": "3",
                            "ce:initials": "F.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Peyvandi",
                            "@auid": "57211730916",
                            "ce:indexed-name": "Peyvandi F."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Italy",
                            "@afid": "60030318",
                            "@country": "ita",
                            "city": "Milan",
                            "organization": [
                                {"$": "Department of Pathophysiology and Transplantation"},
                                {"$": "Universitàdegli Studi di Milano"}
                            ],
                            "affiliation-id": {
                                "@afid": "60030318",
                                "@dptid": "104534016"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-950575767-b9ad2945ae5af673be29d37cd6c63c75-1",
                            "ce:source-text": "Department of Pathophysiology and Transplantation, Universitàdegli Studi di Milano, Milan, Italy",
                            "@dptid": "104534016"
                        },
                        "author": [{
                            "ce:given-name": "Flora",
                            "preferred-name": {
                                "ce:given-name": "Flora",
                                "ce:initials": "F.",
                                "ce:surname": "Peyvandi",
                                "ce:indexed-name": "Peyvandi F."
                            },
                            "@author-instance-id": "OB2BibRecID-950575767-c1d8a516a36013d6f9dbf7149953b20e-1",
                            "@seq": "3",
                            "ce:initials": "F.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Peyvandi",
                            "@auid": "57211730916",
                            "ce:indexed-name": "Peyvandi F."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Ukraine",
                            "@afid": "60068515",
                            "@country": "ukr",
                            "city": "Lviv",
                            "organization": {"$": "Academy of Medical Sciences of Ukraine"},
                            "affiliation-id": {"@afid": "60068515"},
                            "@affiliation-instance-id": "OB2BibRecID-950575767-23df9bd57edb83531a30dd4018beab8d-1",
                            "ce:source-text": "Academy of Medical Sciences of Ukraine, Lviv, Ukraine"
                        },
                        "author": [{
                            "ce:given-name": "Oleksandra",
                            "preferred-name": {
                                "ce:given-name": "Oleksandra",
                                "ce:initials": "O.",
                                "ce:surname": "Stasyshyn",
                                "ce:indexed-name": "Stasyshyn O."
                            },
                            "@author-instance-id": "OB2BibRecID-950575767-deb4e2feca06f75d634f0cb6db4c0c58-1",
                            "@seq": "4",
                            "ce:initials": "O.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Stasyshyn",
                            "@auid": "55786651500",
                            "ce:indexed-name": "Stasyshyn O."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Malaysia",
                            "@afid": "60103837",
                            "@country": "mys",
                            "city": "George Town",
                            "organization": [
                                {"$": "Department of Pediatrics"},
                                {"$": "Hospital Pulau Pinang"}
                            ],
                            "affiliation-id": {
                                "@afid": "60103837",
                                "@dptid": "112348172"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-950575767-6c17dab54d5d95294c9bcda432e739aa-1",
                            "ce:source-text": "Department of Pediatrics, Hospital Pulau Pinang, George Town, Malaysia",
                            "@dptid": "112348172"
                        },
                        "author": [{
                            "ce:given-name": "Seoh Leng",
                            "preferred-name": {
                                "ce:given-name": "Seoh Leng",
                                "ce:initials": "S.L.",
                                "ce:surname": "Yeoh",
                                "ce:indexed-name": "Yeoh S.L."
                            },
                            "@author-instance-id": "OB2BibRecID-950575767-37a3a540775709db6e966ecdcd7f2a96-1",
                            "@seq": "5",
                            "ce:initials": "S.L.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Yeoh",
                            "@auid": "58563992400",
                            "ce:indexed-name": "Yeoh S.L."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Pediatrics"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "103183423"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-950575767-31d8cf1c53bce63684189c9a91e70eec-1",
                            "ce:source-text": "Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "103183423"
                        },
                        "author": [{
                            "ce:given-name": "Darintr",
                            "preferred-name": {
                                "ce:given-name": "Darintr",
                                "ce:initials": "D.",
                                "ce:surname": "Sosothikul",
                                "ce:indexed-name": "Sosothikul D."
                            },
                            "@author-instance-id": "OB2BibRecID-950575767-552bbed9ef18b513dae2bbb5131c99d1-1",
                            "@seq": "6",
                            "ce:initials": "D.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sosothikul",
                            "@auid": "15830686100",
                            "ce:indexed-name": "Sosothikul D."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Integrative and Innovative Hematology/Oncology Research Unit"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalonkorn University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "128282997"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-950575767-298a832c51ab18d1e8d55e4c5a311356-1",
                            "ce:source-text": "Integrative and Innovative Hematology/Oncology Research Unit, Faculty of Medicine, Chulalonkorn University, Bangkok, Thailand",
                            "@dptid": "128282997"
                        },
                        "author": [{
                            "ce:given-name": "Darintr",
                            "preferred-name": {
                                "ce:given-name": "Darintr",
                                "ce:initials": "D.",
                                "ce:surname": "Sosothikul",
                                "ce:indexed-name": "Sosothikul D."
                            },
                            "@author-instance-id": "OB2BibRecID-950575767-552bbed9ef18b513dae2bbb5131c99d1-1",
                            "@seq": "6",
                            "ce:initials": "D.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sosothikul",
                            "@auid": "15830686100",
                            "ce:indexed-name": "Sosothikul D."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Turkey",
                            "@afid": "60087899",
                            "@country": "tur",
                            "city": "Adana",
                            "organization": [
                                {"$": "Department of Pediatric Hematology and Oncology"},
                                {"$": "Acibadem Adana Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60087899",
                                "@dptid": "130155171"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-950575767-7d1cccee1a9174cdfac7566455dfa47f-1",
                            "ce:source-text": "Department of Pediatric Hematology and Oncology, Acibadem Adana Hospital, Adana, Turkey",
                            "@dptid": "130155171"
                        },
                        "author": [{
                            "ce:given-name": "Ali Bulent",
                            "preferred-name": {
                                "ce:given-name": "Ali Bulent",
                                "ce:initials": "A.B.",
                                "ce:surname": "Antmen",
                                "ce:indexed-name": "Antmen A.B."
                            },
                            "@author-instance-id": "OB2BibRecID-950575767-56e40e39a21e3d70ac3c09cfe6c65b21-1",
                            "@seq": "7",
                            "ce:initials": "A.B.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Antmen",
                            "@auid": "57210409659",
                            "ce:indexed-name": "Antmen A.B."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Italy",
                            "@afid": "60112142",
                            "@country": "ita",
                            "city": "Milan",
                            "organization": {"$": "IQVIA"},
                            "affiliation-id": {"@afid": "60112142"},
                            "@affiliation-instance-id": "OB2BibRecID-950575767-f0335836dca321cf57f70c51a076280b-1",
                            "ce:source-text": "IQVIA, Milan, Italy"
                        },
                        "author": [{
                            "ce:given-name": "Caterina",
                            "preferred-name": {
                                "ce:given-name": "Caterina",
                                "ce:initials": "C.",
                                "ce:surname": "Maggiore",
                                "ce:indexed-name": "Maggiore C."
                            },
                            "@author-instance-id": "OB2BibRecID-950575767-a5cdccb350572a7510eca1d9922cf78e-1",
                            "@seq": "8",
                            "ce:initials": "C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Maggiore",
                            "@auid": "57196472137",
                            "ce:indexed-name": "Maggiore C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Austria",
                            "@afid": "123341180",
                            "@country": "aut",
                            "city": "Vienna",
                            "organization": [
                                {"$": "Pharmacometrics & Biostatistics"},
                                {"$": "Baxalta Innovations GmbH"},
                                {"$": "A Takeda Company"}
                            ],
                            "affiliation-id": {
                                "@afid": "123341180",
                                "@dptid": "130154593"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-950575767-1e65196f5bcf6a26c47321c92774fdaa-1",
                            "ce:source-text": "Pharmacometrics & Biostatistics, Baxalta Innovations GmbH, A Takeda Company, Vienna, Austria",
                            "@dptid": "130154593"
                        },
                        "author": [{
                            "ce:given-name": "Werner",
                            "preferred-name": {
                                "ce:given-name": "Werner",
                                "ce:initials": "W.",
                                "ce:surname": "Engl",
                                "ce:indexed-name": "Engl W."
                            },
                            "@author-instance-id": "OB2BibRecID-950575767-0fddd938035cf700ad8797c3a73a767a-1",
                            "@seq": "9",
                            "ce:initials": "W.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Engl",
                            "@auid": "13102650700",
                            "ce:indexed-name": "Engl W."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "127686493",
                            "@country": "usa",
                            "city": "Cambridge",
                            "organization": [
                                {"$": "Takeda Development Center Americas"},
                                {"$": "Inc"}
                            ],
                            "affiliation-id": {"@afid": "127686493"},
                            "state": "MA",
                            "@affiliation-instance-id": "OB2BibRecID-950575767-457a0df3c7ae453179d538d7e0db498d-1",
                            "ce:source-text": "Takeda Development Center Americas, Inc, Cambridge, MA, USA"
                        },
                        "author": [
                            {
                                "ce:given-name": "Bruce",
                                "preferred-name": {
                                    "ce:given-name": "Bruce",
                                    "ce:initials": "B.",
                                    "ce:surname": "Ewenstein",
                                    "ce:indexed-name": "Ewenstein B."
                                },
                                "@author-instance-id": "OB2BibRecID-950575767-7379ddf2882e4056a2baad5de6bf1ffd-1",
                                "@seq": "10",
                                "ce:initials": "B.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Ewenstein",
                                "@auid": "57209646919",
                                "ce:indexed-name": "Ewenstein B."
                            },
                            {
                                "ce:given-name": "Srilatha",
                                "preferred-name": {
                                    "ce:given-name": "Srilatha",
                                    "ce:initials": "S.",
                                    "ce:surname": "Tangada",
                                    "ce:indexed-name": "Tangada S."
                                },
                                "@author-instance-id": "OB2BibRecID-950575767-36ea94d1f6e1b1c101c624b76d438b1c-1",
                                "@seq": "11",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Tangada",
                                "@auid": "6506136597",
                                "ce:indexed-name": "Tangada S."
                            }
                        ]
                    }
                ],
                "citation-title": "Immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A: interim results from a phase 3, prospective, multicenter, open-label study",
                "abstracts": "© 2023 TakedaDevelopment Center Americas, Inc. Published by Informa UK Limited, trading as Taylor & Francis Group.Aim: To determine the immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients (PUPs) with severe hemophilia A (HA). Methods: This prospective, phase 3 study (NCT02615691) was conducted in PUPs, or patients with ≤2 exposure days (EDs) prior to screening, aged <6 years with severe HA. The primary endpoint was incidence of factor VIII (FVIII) inhibitor development. This protocol-specified interim analysis was conducted after 50 patients had completed ≥50 EDs without developing FVIII inhibitors or had developed a confirmed inhibitor at any time. Results: Of the enrolled patients, 59/80 (73.8%) received ≥1 dose of rurioctocog alfa pegol; 54 received prophylaxis, and 35 on-demand treatment. Incidence of inhibitor development was 0.19 (10/52). Total annualized bleeding rate (95% CIs) was 3.2 (2.0\u20135.0) for patients receiving prophylaxis and 3.2 (1.6\u20136.3) for on-demand treatment. Hemostatic efficacy of most bleedings was rated as \u2018excellent\u2019 or \u2018good\u2019 after 24 hours (122/131 [93.1%]) and at resolution (161/170 [94.7%]). Five patients received ≥1 dose of rurioctocog alfa pegol for immune tolerance induction (ITI) and 1 patient was defined as having ITI success. Thirteen patients experienced 14 treatment-related adverse events, including 10 cases of FVIII inhibitor development. Conclusion: This is the first prospective study of rurioctocog alfa pegol for the treatment of PUPs with severe HA. Trial Registration: This trial is registered at ClinicalTrials.gov (CT.gov identifier: NCT02615691).",
                "correspondence": {
                    "affiliation": {
                        "country": "United States",
                        "address-part": "650 East Kendall Street",
                        "postal-code": "02142",
                        "@country": "usa",
                        "city": "Cambridge",
                        "organization": [
                            {"$": "Takeda Development Center Americas"},
                            {"$": "Inc"}
                        ],
                        "state": "MA",
                        "@affiliation-instance-id": "OB2BibRecID-950575767-cbfb615f2bdb3f83ebc678d3207822d0-1",
                        "ce:source-text": "Takeda Development Center Americas, Inc, 650 East Kendall Street, Cambridge, MA, 02142, USA"
                    },
                    "person": {
                        "ce:given-name": "Srilatha",
                        "@author-instance-id": "OB2BibRecID-950575767-6b7322249bfa444351cd634118d1e2ab-1",
                        "ce:initials": "S.",
                        "ce:surname": "Tangada",
                        "ce:indexed-name": "Tangada S."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Antibodies",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "factor VIII",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "hemophilia A",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "inhibitors",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "prophylaxis",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "safety",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "Expert Rev. Hematol.",
                    "website": {"ce:e-address": {
                        "$": "http://www.tandfonline.com/loi/ierr20",
                        "@type": "email"
                    }},
                    "@country": "gbr",
                    "translated-sourcetitle": {
                        "$": "Expert Review of Hematology",
                        "@xml:lang": "eng"
                    },
                    "issn": [
                        {
                            "$": "17474094",
                            "@type": "electronic"
                        },
                        {
                            "$": "17474086",
                            "@type": "print"
                        }
                    ],
                    "@type": "j",
                    "publicationyear": {"@first": "2023"},
                    "publisher": {"publishername": "Taylor and Francis Ltd."},
                    "sourcetitle": "Expert Review of Hematology",
                    "@srcid": "19700174994",
                    "publicationdate": {
                        "year": "2023",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "2023"
                        }
                    }
                },
                "enhancement": {"classificationgroup": {"classifications": [
                    {
                        "@type": "ASJC",
                        "classification": "2720"
                    },
                    {
                        "@type": "SUBJABBR",
                        "classification": "MEDI"
                    }
                ]}}
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2023 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "Publisher",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "09",
                    "@timestamp": "BST 14:56:33",
                    "@year": "2023",
                    "@month": "09"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2025310063",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "642141978",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "950575767",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20230837565",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "37646148",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20232696366",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20233364963",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20239030042375",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85169881680",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85169881680",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:doi": "10.1080/17474086.2023.2247160"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "34",
                "reference": [
                    {
                        "ref-fulltext": "Mannucci PM, Tuddenham EG. The hemophilias\u2013from royal genes to gene therapy. N Engl J Med. 2001; 344 (23): 1773\u20131779. doi: 10.1056/NEJM200106073442307",
                        "@reference-instance-id": "OB2BibRecID-950575767-c93f2a65fa0e6db2cbaff23f4045b217-1",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "The hemophilias\u2013from royal genes to gene therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJM200106073442307",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0035822038",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "344",
                                    "@issue": "23"
                                },
                                "pagerange": {
                                    "@first": "1773",
                                    "@last": "1779"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Mannucci",
                                    "ce:indexed-name": "Mannucci P.M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Tuddenham",
                                    "ce:indexed-name": "Tuddenham E.G."
                                }
                            ]},
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Mannucci PM, Tuddenham EG. The hemophilias\u2013from royal genes to gene therapy. N Engl J Med. 2001; 344 (23): 1773\u20131779. doi: 10.1056/NEJM200106073442307"
                    },
                    {
                        "ref-fulltext": "Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet. 2003; 361 (9371): 1801\u20131809. doi: 10.1016/S0140-6736(03)13405-8",
                        "@reference-instance-id": "OB2BibRecID-950575767-24d6a82f8cbc27169239790fcd43c39e-2",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Haemophilias A and B"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S0140-6736(03)13405-8",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0002",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0038101450",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "361",
                                    "@issue": "9371"
                                },
                                "pagerange": {
                                    "@first": "1801",
                                    "@last": "1809"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Bolton-Maggs",
                                    "ce:indexed-name": "Bolton-Maggs P.H."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Pasi",
                                    "ce:indexed-name": "Pasi K.J."
                                }
                            ]},
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet. 2003; 361 (9371): 1801\u20131809. doi: 10.1016/S0140-6736(03)13405-8"
                    },
                    {
                        "ref-fulltext": "Srivastava A, Santagostino E, Dougall A, et al. WFH Guidelines for the management of hemophilia, 3rd edition. Haemophilia. 2020; 26 (Suppl 6): 1\u2013158. doi: 10.1111/hae.14046",
                        "@reference-instance-id": "OB2BibRecID-950575767-09b1e86239426dcabe70b57564a592e6-3",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "WFH Guidelines for the management of hemophilia, 3rd edition"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/hae.14046",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0003",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85092332111",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "26"},
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "158"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Srivastava",
                                        "ce:indexed-name": "Srivastava A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Santagostino",
                                        "ce:indexed-name": "Santagostino E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Dougall",
                                        "ce:indexed-name": "Dougall A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Haemophilia"
                        },
                        "ce:source-text": "Srivastava A, Santagostino E, Dougall A, et al. WFH Guidelines for the management of hemophilia, 3rd edition. Haemophilia. 2020; 26 (Suppl 6): 1\u2013158. doi: 10.1111/hae.14046"
                    },
                    {
                        "ref-fulltext": "Peyvandi F, Garagiola I, Young G. The past and future of haemophilia: diagnosis, treatments, and its complications. Lancet. 2016; 388 (10040): 187\u2013197. doi: 10.1016/S0140-6736(15)01123-X",
                        "@reference-instance-id": "OB2BibRecID-950575767-786ba44060a0cdcab50359795b45d953-4",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "The past and future of haemophilia: diagnosis, treatments, and its complications"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S0140-6736(15)01123-X",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0004",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84958580623",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "388"},
                                "pagerange": {
                                    "@first": "187",
                                    "@last": "197"
                                }
                            },
                            "ref-text": "10040",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Peyvandi",
                                    "ce:indexed-name": "Peyvandi F."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "I.",
                                    "@_fa": "true",
                                    "ce:surname": "Garagiola",
                                    "ce:indexed-name": "Garagiola I."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Young",
                                    "ce:indexed-name": "Young G."
                                }
                            ]},
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Peyvandi F, Garagiola I, Young G. The past and future of haemophilia: diagnosis, treatments, and its complications. Lancet. 2016; 388 (10040): 187\u2013197. doi: 10.1016/S0140-6736(15)01123-X"
                    },
                    {
                        "ref-fulltext": "Ljung R. Aspects of prophylactic treatment of hemophilia. Thromb J. 2016; 14 (Suppl 1): 30. doi: 10.1186/s12959-016-0103-3",
                        "@reference-instance-id": "OB2BibRecID-950575767-8fb4be829238780307a25c39b503e0a4-5",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Aspects of prophylactic treatment of hemophilia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s12959-016-0103-3",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0005",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84990041946",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {"@first": "30"}
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "R.",
                                "@_fa": "true",
                                "ce:surname": "Ljung",
                                "ce:indexed-name": "Ljung R."
                            }]},
                            "ref-sourcetitle": "Thromb J"
                        },
                        "ce:source-text": "Ljung R. Aspects of prophylactic treatment of hemophilia. Thromb J. 2016; 14 (Suppl 1): 30. doi: 10.1186/s12959-016-0103-3"
                    },
                    {
                        "ref-fulltext": "Witmer C, Young G. Factor VIII inhibitors in hemophilia A: rationale and latest evidence. Ther Adv Hematol. 2013; 4 (1): 59\u201372. doi: 10.1177/2040620712464509",
                        "@reference-instance-id": "OB2BibRecID-950575767-81eb0ab7fdfd8118e047a9a427f979cf-6",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Factor VIII inhibitors in hemophilia A: rationale and latest evidence"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1177/2040620712464509",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0006",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84993661361",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "4",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "59",
                                    "@last": "72"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Witmer",
                                    "ce:indexed-name": "Witmer C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Young",
                                    "ce:indexed-name": "Young G."
                                }
                            ]},
                            "ref-sourcetitle": "Ther Adv Hematol"
                        },
                        "ce:source-text": "Witmer C, Young G. Factor VIII inhibitors in hemophilia A: rationale and latest evidence. Ther Adv Hematol. 2013; 4 (1): 59\u201372. doi: 10.1177/2040620712464509"
                    },
                    {
                        "ref-fulltext": "Prezotti ANL, Frade-Guanaes JO, Yamaguti-Hayakawa GG, et al. Immunogenicity of current and new therapies for hemophilia A. Pharmaceuticals. 2022; 15 (8): 911. doi: 10.3390/ph15080911",
                        "@reference-instance-id": "OB2BibRecID-950575767-58771a4edd3761f871a5a72aa88bbac5-7",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Immunogenicity of current and new therapies for hemophilia A"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3390/ph15080911",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0007",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85137324337",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "15",
                                    "@issue": "8"
                                },
                                "pagerange": {"@first": "911"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.N.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Prezotti",
                                        "ce:indexed-name": "Prezotti A.N.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.O.",
                                        "@_fa": "true",
                                        "ce:surname": "Frade-Guanaes",
                                        "ce:indexed-name": "Frade-Guanaes J.O."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Yamaguti-Hayakawa",
                                        "ce:indexed-name": "Yamaguti-Hayakawa G.G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharmaceuticals"
                        },
                        "ce:source-text": "Prezotti ANL, Frade-Guanaes JO, Yamaguti-Hayakawa GG, et al. Immunogenicity of current and new therapies for hemophilia A. Pharmaceuticals. 2022; 15 (8): 911. doi: 10.3390/ph15080911"
                    },
                    {
                        "ref-fulltext": "Jardim LL, Chaves DG, Rezende SM. Development of inhibitors in hemophilia A: An illustrated review. Res Pract Thromb Haemost. 2020; 4 (5): 752\u2013760. doi: 10.1002/rth2.12335",
                        "@reference-instance-id": "OB2BibRecID-950575767-57e4b708fa1af7dde1288a18c60a071f-8",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Development of inhibitors in hemophilia A: An illustrated review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/rth2.12335",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0008",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85106417641",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "4",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "752",
                                    "@last": "760"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Jardim",
                                    "ce:indexed-name": "Jardim L.L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Chaves",
                                    "ce:indexed-name": "Chaves D.G."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Rezende",
                                    "ce:indexed-name": "Rezende S.M."
                                }
                            ]},
                            "ref-sourcetitle": "Res Pract Thromb Haemost"
                        },
                        "ce:source-text": "Jardim LL, Chaves DG, Rezende SM. Development of inhibitors in hemophilia A: An illustrated review. Res Pract Thromb Haemost. 2020; 4 (5): 752\u2013760. doi: 10.1002/rth2.12335"
                    },
                    {
                        "ref-fulltext": "Bray G. Inhibitor questions: plasma-derived factor VIII and recombinant factor VIII. Ann Hematol. 1994; 68 (Suppl 3): S29\u201334. doi: 10.1007/BF01774527",
                        "@reference-instance-id": "OB2BibRecID-950575767-b663ef23ef9167a4417ac1b74b8f22f1-9",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1994"},
                            "ref-title": {"ref-titletext": "Inhibitor questions: plasma-derived factor VIII and recombinant factor VIII"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/BF01774527",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0009",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0028258572",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "68"},
                                "pagerange": {
                                    "@first": "S29",
                                    "@last": "S34"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "G.",
                                "@_fa": "true",
                                "ce:surname": "Bray",
                                "ce:indexed-name": "Bray G."
                            }]},
                            "ref-sourcetitle": "Ann Hematol"
                        },
                        "ce:source-text": "Bray G. Inhibitor questions: plasma-derived factor VIII and recombinant factor VIII. Ann Hematol. 1994; 68 (Suppl 3): S29\u201334. doi: 10.1007/BF01774527"
                    },
                    {
                        "ref-fulltext": "Liesner RJ, Abraham A, Altisent C, et al. Simoctocog alfa (Nuwiq) in previously untreated patients with severe haemophilia A: Final results of the NuProtect study. Thromb Haemost. 2021; 121 (11): 1400\u20131408. doi: 10.1055/s-0040-1722623",
                        "@reference-instance-id": "OB2BibRecID-950575767-1eeb52d008a84fcb7ba06044032058f5-10",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Simoctocog alfa (Nuwiq) in previously untreated patients with severe haemophilia A: Final results of the NuProtect study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1055/s-0040-1722623",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0010",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85100877987",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "121",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "1400",
                                    "@last": "1408"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Liesner",
                                        "ce:indexed-name": "Liesner R.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Abraham",
                                        "ce:indexed-name": "Abraham A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Altisent",
                                        "ce:indexed-name": "Altisent C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Thromb Haemost"
                        },
                        "ce:source-text": "Liesner RJ, Abraham A, Altisent C, et al. Simoctocog alfa (Nuwiq) in previously untreated patients with severe haemophilia A: Final results of the NuProtect study. Thromb Haemost. 2021; 121 (11): 1400\u20131408. doi: 10.1055/s-0040-1722623"
                    },
                    {
                        "ref-fulltext": "Morfini M, Haya S, Tagariello G, et al. European study on orthopaedic status of haemophilia patients with inhibitors. Haemophilia. 2007; 13 (5): 606\u2013612. doi: 10.1111/j.1365-2516.2007.01518.x",
                        "@reference-instance-id": "OB2BibRecID-950575767-8d1655f63dcbcb479447f538eff2018f-11",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "European study on orthopaedic status of haemophilia patients with inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/j.1365-2516.2007.01518.x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0011",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "34548304886",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "13",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "606",
                                    "@last": "612"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Morfini",
                                        "ce:indexed-name": "Morfini M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Haya",
                                        "ce:indexed-name": "Haya S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Tagariello",
                                        "ce:indexed-name": "Tagariello G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Haemophilia"
                        },
                        "ce:source-text": "Morfini M, Haya S, Tagariello G, et al. European study on orthopaedic status of haemophilia patients with inhibitors. Haemophilia. 2007; 13 (5): 606\u2013612. doi: 10.1111/j.1365-2516.2007.01518.x"
                    },
                    {
                        "ref-fulltext": "Walsh CE, Soucie JM, Miler CH, et al. Impact of inhibitors on hemophilia A mortality in the United States. Am J Hematol. 2015; 90 (5): 400\u2013405. doi: 10.1002/ajh.23957",
                        "@reference-instance-id": "OB2BibRecID-950575767-067136810178fd47d74fef8284794d23-12",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Impact of inhibitors on hemophilia A mortality in the United States"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/ajh.23957",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0012",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84928272570",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "90",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "400",
                                    "@last": "405"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Walsh",
                                        "ce:indexed-name": "Walsh C.E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Soucie",
                                        "ce:indexed-name": "Soucie J.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Miler",
                                        "ce:indexed-name": "Miler C.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Hematol"
                        },
                        "ce:source-text": "Walsh CE, Soucie JM, Miler CH, et al. Impact of inhibitors on hemophilia A mortality in the United States. Am J Hematol. 2015; 90 (5): 400\u2013405. doi: 10.1002/ajh.23957"
                    },
                    {
                        "ref-fulltext": "Nerich V, Tissot E, Faradji A, et al. Cost-of-illness study of severe haemophilia A and B in five French haemophilia treatment centres. Pharm World Sci. 2008; 30 (3): 287\u2013292. doi: 10.1007/s11096-007-9181-4",
                        "@reference-instance-id": "OB2BibRecID-950575767-93c8a558498d884e848e50ad7a35bc2a-13",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Cost-of-illness study of severe haemophilia A and B in five French haemophilia treatment centres"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s11096-007-9181-4",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0013",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "42249098471",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "30",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "287",
                                    "@last": "292"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Nerich",
                                        "ce:indexed-name": "Nerich V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Tissot",
                                        "ce:indexed-name": "Tissot E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Faradji",
                                        "ce:indexed-name": "Faradji A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharm World Sci"
                        },
                        "ce:source-text": "Nerich V, Tissot E, Faradji A, et al. Cost-of-illness study of severe haemophilia A and B in five French haemophilia treatment centres. Pharm World Sci. 2008; 30 (3): 287\u2013292. doi: 10.1007/s11096-007-9181-4"
                    },
                    {
                        "ref-fulltext": "Iorio A, Halimeh S, Holzhauer S, et al. Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review. J Thromb Haemost. 2010; 8 (6): 1256\u20131265. doi: 10.1111/j.1538-7836.2010.03823.x",
                        "@reference-instance-id": "OB2BibRecID-950575767-52b3826df594b3a8f651d2f0eafd4a17-14",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/j.1538-7836.2010.03823.x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0014",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "77954506432",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1256",
                                    "@last": "1265"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Iorio",
                                        "ce:indexed-name": "Iorio A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Halimeh",
                                        "ce:indexed-name": "Halimeh S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Holzhauer",
                                        "ce:indexed-name": "Holzhauer S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Thromb Haemost"
                        },
                        "ce:source-text": "Iorio A, Halimeh S, Holzhauer S, et al. Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review. J Thromb Haemost. 2010; 8 (6): 1256\u20131265. doi: 10.1111/j.1538-7836.2010.03823.x"
                    },
                    {
                        "ref-fulltext": "Dimichele D. Immune tolerance therapy for factor VIII inhibitors: moving from empiricism to an evidence-based approach. J Thromb Haemost. 2007; 5 (Suppl 1): 143\u2013150. doi: 10.1111/j.1538-7836.2007.02474.x",
                        "@reference-instance-id": "OB2BibRecID-950575767-e5d9303f8c219bf0c6698342115750ef-15",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Immune tolerance therapy for factor VIII inhibitors: moving from empiricism to an evidence-based approach"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/j.1538-7836.2007.02474.x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0015",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "34250712964",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "5"},
                                "pagerange": {
                                    "@first": "143",
                                    "@last": "150"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "D.",
                                "@_fa": "true",
                                "ce:surname": "Dimichele",
                                "ce:indexed-name": "Dimichele D."
                            }]},
                            "ref-sourcetitle": "J Thromb Haemost"
                        },
                        "ce:source-text": "Dimichele D. Immune tolerance therapy for factor VIII inhibitors: moving from empiricism to an evidence-based approach. J Thromb Haemost. 2007; 5 (Suppl 1): 143\u2013150. doi: 10.1111/j.1538-7836.2007.02474.x"
                    },
                    {
                        "ref-fulltext": "Jefferis R. Posttranslational Modifications and the Immunogenicity of Biotherapeutics. J Immunol Res. 2016; 2016: 5358272. doi: 10.1155/2016/5358272",
                        "@reference-instance-id": "OB2BibRecID-950575767-c928ec91457f0ef3109948d8069159a3-16",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Posttranslational Modifications and the Immunogenicity of Biotherapeutics"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1155/2016/5358272",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0016",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84966770027",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2016"},
                                "pagerange": {"@first": "5358272"}
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "R.",
                                "@_fa": "true",
                                "ce:surname": "Jefferis",
                                "ce:indexed-name": "Jefferis R."
                            }]},
                            "ref-sourcetitle": "J Immunol Res"
                        },
                        "ce:source-text": "Jefferis R. Posttranslational Modifications and the Immunogenicity of Biotherapeutics. J Immunol Res. 2016; 2016: 5358272. doi: 10.1155/2016/5358272"
                    },
                    {
                        "ref-fulltext": "Kozma GT, Shimizu T, Ishida T, et al. Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals. Adv Drug Deliv Rev. 2020; 154-155: 163\u2013175. doi: 10.1016/j.addr.2020.07.024",
                        "@reference-instance-id": "OB2BibRecID-950575767-ccd8a7585ee2ae1959df82aea863d764-17",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.addr.2020.07.024",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0017",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089287673",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "154-155"},
                                "pagerange": {
                                    "@first": "163",
                                    "@last": "175"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Kozma",
                                        "ce:indexed-name": "Kozma G.T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Shimizu",
                                        "ce:indexed-name": "Shimizu T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Ishida",
                                        "ce:indexed-name": "Ishida T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Adv Drug Deliv Rev"
                        },
                        "ce:source-text": "Kozma GT, Shimizu T, Ishida T, et al. Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals. Adv Drug Deliv Rev. 2020; 154-155: 163\u2013175. doi: 10.1016/j.addr.2020.07.024"
                    },
                    {
                        "ref-fulltext": "Verbruggen B, Novakova I, Wessels H, et al. The Nijmegen modification of the Bethesda assay for factor VIII: C inhibitors: improved specificity and reliability. Thromb Haemost. 1995; 73 (2): 247\u2013251. doi: 10.1055/s-0038-1653759",
                        "@reference-instance-id": "OB2BibRecID-950575767-f274763bc6f79f3e7c2782877282f3b9-18",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1995"},
                            "ref-title": {"ref-titletext": "The Nijmegen modification of the Bethesda assay for factor VIII: C inhibitors: improved specificity and reliability"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1055/s-0038-1653759",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0018",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0028837315",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "73",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "247",
                                    "@last": "251"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Verbruggen",
                                        "ce:indexed-name": "Verbruggen B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Novakova",
                                        "ce:indexed-name": "Novakova I."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Wessels",
                                        "ce:indexed-name": "Wessels H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Thromb Haemost"
                        },
                        "ce:source-text": "Verbruggen B, Novakova I, Wessels H, et al. The Nijmegen modification of the Bethesda assay for factor VIII: C inhibitors: improved specificity and reliability. Thromb Haemost. 1995; 73 (2): 247\u2013251. doi: 10.1055/s-0038-1653759"
                    },
                    {
                        "ref-fulltext": "Whelan SFJ, Hofbauer CJ, Horling FM, et al. Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients. Blood. 2013; 121 (6): 1039\u20131048. doi: 10.1182/blood-2012-07-444877",
                        "@reference-instance-id": "OB2BibRecID-950575767-55e97f870ae2c43913a785e267b38bf3-19",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2012-07-444877",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0019",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84873583409",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "121",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1039",
                                    "@last": "1048"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.F.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Whelan",
                                        "ce:indexed-name": "Whelan S.F.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Hofbauer",
                                        "ce:indexed-name": "Hofbauer C.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Horling",
                                        "ce:indexed-name": "Horling F.M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Whelan SFJ, Hofbauer CJ, Horling FM, et al. Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients. Blood. 2013; 121 (6): 1039\u20131048. doi: 10.1182/blood-2012-07-444877"
                    },
                    {
                        "ref-fulltext": "Lubich C, Allacher P, de la Rosa M, et al. The mystery of antibodies against polyethylene glycol (PEG)\u2013what do we know? Pharm Res. 2016; 33 (9): 2239\u20132249. doi: 10.1007/s11095-016-1961-x",
                        "@reference-instance-id": "OB2BibRecID-950575767-d708aff745930c3a33606567bd82d345-20",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "The mystery of antibodies against polyethylene glycol (PEG)\u2013what do we know?"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s11095-016-1961-x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0020",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84976314592",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "33",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "2239",
                                    "@last": "2249"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Lubich",
                                        "ce:indexed-name": "Lubich C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Allacher",
                                        "ce:indexed-name": "Allacher P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "de la Rosa",
                                        "ce:indexed-name": "de la Rosa M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharm Res"
                        },
                        "ce:source-text": "Lubich C, Allacher P, de la Rosa M, et al. The mystery of antibodies against polyethylene glycol (PEG)\u2013what do we know? Pharm Res. 2016; 33 (9): 2239\u20132249. doi: 10.1007/s11095-016-1961-x"
                    },
                    {
                        "ref-fulltext": "Hay CRM, DiMichele D. The principal results of the International Immune Tolerance Study: a randomized dose comparison. Blood. 2012; 119 (6): 1335\u20131344. doi: 10.1182/blood-2011-08-369132",
                        "@reference-instance-id": "OB2BibRecID-950575767-72202e573e2e98649582ec6ca06eede8-21",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "The principal results of the International Immune Tolerance Study: a randomized dose comparison"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2011-08-369132",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0021",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84856866914",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "119",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1335",
                                    "@last": "1344"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.R.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Hay",
                                    "ce:indexed-name": "Hay C.R.M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "DiMichele",
                                    "ce:indexed-name": "DiMichele D."
                                }
                            ]},
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Hay CRM, DiMichele D. The principal results of the International Immune Tolerance Study: a randomized dose comparison. Blood. 2012; 119 (6): 1335\u20131344. doi: 10.1182/blood-2011-08-369132"
                    },
                    {
                        "ref-fulltext": "Gouw SC, van der Bom JG, Auerswald G, et al. Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study. Blood. 2007; 109 (11): 4693\u20134697. doi: 10.1182/blood-2006-11-056317",
                        "@reference-instance-id": "OB2BibRecID-950575767-f84264ac73329ac4604e768c75cac7a4-22",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2006-11-056317",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0022",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "34249711370",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "109",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "4693",
                                    "@last": "4697"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Gouw",
                                        "ce:indexed-name": "Gouw S.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.G.",
                                        "@_fa": "true",
                                        "ce:surname": "van der Bom",
                                        "ce:indexed-name": "van der Bom J.G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Auerswald",
                                        "ce:indexed-name": "Auerswald G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Gouw SC, van der Bom JG, Auerswald G, et al. Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study. Blood. 2007; 109 (11): 4693\u20134697. doi: 10.1182/blood-2006-11-056317"
                    },
                    {
                        "ref-fulltext": "Kempton CL, White GC. How we treat a hemophilia A patient with a factor VIII inhibitor. Blood. 2009; 113 (1): 11\u201317. doi: 10.1182/blood-2008-06-160432",
                        "@reference-instance-id": "OB2BibRecID-950575767-592031c30dd9434a11f993befea67d82-23",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "How we treat a hemophilia A patient with a factor VIII inhibitor"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2008-06-160432",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0023",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "59449097322",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "113",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "11",
                                    "@last": "17"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Kempton",
                                    "ce:indexed-name": "Kempton C.L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "G.C.",
                                    "@_fa": "true",
                                    "ce:surname": "White",
                                    "ce:indexed-name": "White G.C."
                                }
                            ]},
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Kempton CL, White GC. How we treat a hemophilia A patient with a factor VIII inhibitor. Blood. 2009; 113 (1): 11\u201317. doi: 10.1182/blood-2008-06-160432"
                    },
                    {
                        "ref-fulltext": "Stidl R, Fuchs S, Bossard M, et al. Safety of PEGylated recombinant human full-length coagulation factor VIII (BAX 855) in the overall context of PEG and PEG conjugates. Haemophilia. 2016; 22 (1): 54\u201364. doi: 10.1111/hae.12762",
                        "@reference-instance-id": "OB2BibRecID-950575767-df3a83613082af6dac5d2fd98d97e33c-24",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Safety of PEGylated recombinant human full-length coagulation factor VIII (BAX 855) in the overall context of PEG and PEG conjugates"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/hae.12762",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0024",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84959041547",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "54",
                                    "@last": "64"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Stidl",
                                        "ce:indexed-name": "Stidl R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Fuchs",
                                        "ce:indexed-name": "Fuchs S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Bossard",
                                        "ce:indexed-name": "Bossard M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Haemophilia"
                        },
                        "ce:source-text": "Stidl R, Fuchs S, Bossard M, et al. Safety of PEGylated recombinant human full-length coagulation factor VIII (BAX 855) in the overall context of PEG and PEG conjugates. Haemophilia. 2016; 22 (1): 54\u201364. doi: 10.1111/hae.12762"
                    },
                    {
                        "ref-fulltext": "Liesner RJ, Abashidze M, Aleinikova O, et al. Immunogenicity, efficacy and safety of Nuwiq® (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect study. Haemophilia. 2018; 24 (2): 211\u2013220. doi: 10.1111/hae.13320",
                        "@reference-instance-id": "OB2BibRecID-950575767-ff907935b224e1935f046bf7fec200ba-25",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Immunogenicity, efficacy and safety of Nuwiq® (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/hae.13320",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0025",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85044613691",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "24",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "211",
                                    "@last": "220"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Liesner",
                                        "ce:indexed-name": "Liesner R.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Abashidze",
                                        "ce:indexed-name": "Abashidze M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "O.",
                                        "@_fa": "true",
                                        "ce:surname": "Aleinikova",
                                        "ce:indexed-name": "Aleinikova O."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Haemophilia"
                        },
                        "ce:source-text": "Liesner RJ, Abashidze M, Aleinikova O, et al. Immunogenicity, efficacy and safety of Nuwiq® (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect study. Haemophilia. 2018; 24 (2): 211\u2013220. doi: 10.1111/hae.13320"
                    },
                    {
                        "ref-fulltext": "Yaish H, Matsushita T, Belhani M, et al. Safety and efficacy of turoctocog alfa in the prevention and treatment of bleeds in previously untreated paediatric patients with severe haemophilia A: Results from the guardian 4 multinational clinical trial. Haemophilia. 2020; 26 (1): 64\u201372. doi: 10.1111/hae.13883",
                        "@reference-instance-id": "OB2BibRecID-950575767-9a745adbe4f433b73b2c78b7b23a9c03-26",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Safety and efficacy of turoctocog alfa in the prevention and treatment of bleeds in previously untreated paediatric patients with severe haemophilia A: Results from the guardian 4 multinational clinical trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/hae.13883",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0026",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85076355454",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "26",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "64",
                                    "@last": "72"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Yaish",
                                        "ce:indexed-name": "Yaish H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Matsushita",
                                        "ce:indexed-name": "Matsushita T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Belhani",
                                        "ce:indexed-name": "Belhani M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Haemophilia"
                        },
                        "ce:source-text": "Yaish H, Matsushita T, Belhani M, et al. Safety and efficacy of turoctocog alfa in the prevention and treatment of bleeds in previously untreated paediatric patients with severe haemophilia A: Results from the guardian 4 multinational clinical trial. Haemophilia. 2020; 26 (1): 64\u201372. doi: 10.1111/hae.13883"
                    },
                    {
                        "ref-fulltext": "Collins PW, Palmer BP, Chalmers EA, et al. Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011. Blood. 2014; 124 (23): 3389\u20133397. doi: 10.1182/blood-2014-07-580498",
                        "@reference-instance-id": "OB2BibRecID-950575767-60b7f115098dd429b436bc462e7d8025-27",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2014-07-580498",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0027",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84914142516",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "124",
                                    "@issue": "23"
                                },
                                "pagerange": {
                                    "@first": "3389",
                                    "@last": "3397"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Collins",
                                        "ce:indexed-name": "Collins P.W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Palmer",
                                        "ce:indexed-name": "Palmer B.P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Chalmers",
                                        "ce:indexed-name": "Chalmers E.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Collins PW, Palmer BP, Chalmers EA, et al. Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011. Blood. 2014; 124 (23): 3389\u20133397. doi: 10.1182/blood-2014-07-580498"
                    },
                    {
                        "ref-fulltext": "Peyvandi F, Mannucci PM, Garagiola I, et al. A randomized trial of factor VIII and Neutralizing antibodies in hemophilia A. N Engl J Med. 2016; 374 (21): 2054\u20132064. doi: 10.1056/NEJMoa1516437",
                        "@reference-instance-id": "OB2BibRecID-950575767-489e27fdd505a212052fedd24d1129b3-28",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "A randomized trial of factor VIII and Neutralizing antibodies in hemophilia A"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa1516437",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0028",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84971222569",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "374",
                                    "@issue": "21"
                                },
                                "pagerange": {
                                    "@first": "2054",
                                    "@last": "2064"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Peyvandi",
                                        "ce:indexed-name": "Peyvandi F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Mannucci",
                                        "ce:indexed-name": "Mannucci P.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Garagiola",
                                        "ce:indexed-name": "Garagiola I."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Peyvandi F, Mannucci PM, Garagiola I, et al. A randomized trial of factor VIII and Neutralizing antibodies in hemophilia A. N Engl J Med. 2016; 374 (21): 2054\u20132064. doi: 10.1056/NEJMoa1516437"
                    },
                    {
                        "ref-fulltext": "Male C, Konigs C, Dey S, et al. The safety and efficacy of N8-GP (turoctocog alfa pegol) in previously untreated pediatric patients with hemophilia A. Blood Adv. 2022; 7: 620\u2013629. doi: 10.1182/bloodadvances.2022007529",
                        "@reference-instance-id": "OB2BibRecID-950575767-2f73bc292a5042314bf26307785e037d-29",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "The safety and efficacy of N8-GP (turoctocog alfa pegol) in previously untreated pediatric patients with hemophilia A"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/bloodadvances.2022007529",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0029",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85146458280",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "620",
                                    "@last": "629"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Male",
                                        "ce:indexed-name": "Male C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Konigs",
                                        "ce:indexed-name": "Konigs C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Dey",
                                        "ce:indexed-name": "Dey S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Adv"
                        },
                        "ce:source-text": "Male C, Konigs C, Dey S, et al. The safety and efficacy of N8-GP (turoctocog alfa pegol) in previously untreated pediatric patients with hemophilia A. Blood Adv. 2022; 7: 620\u2013629. doi: 10.1182/bloodadvances.2022007529"
                    },
                    {
                        "ref-fulltext": "Auerswald G, Thompson AA, Recht M, et al. Experience of Advate rAHF-PFM in previously untreated patients and minimally treated patients with haemophilia A. Thromb Haemost. 2012; 107 (6): 1072\u20131082. doi: 10.1160/TH11-09-0642",
                        "@reference-instance-id": "OB2BibRecID-950575767-55b002960a36ef39a7a476cb001f2b7d-30",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Experience of Advate rAHF-PFM in previously untreated patients and minimally treated patients with haemophilia A"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1160/TH11-09-0642",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0030",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84861735411",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "107",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1072",
                                    "@last": "1082"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Auerswald",
                                        "ce:indexed-name": "Auerswald G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Thompson",
                                        "ce:indexed-name": "Thompson A.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Recht",
                                        "ce:indexed-name": "Recht M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Thromb Haemost"
                        },
                        "ce:source-text": "Auerswald G, Thompson AA, Recht M, et al. Experience of Advate rAHF-PFM in previously untreated patients and minimally treated patients with haemophilia A. Thromb Haemost. 2012; 107 (6): 1072\u20131082. doi: 10.1160/TH11-09-0642"
                    },
                    {
                        "ref-fulltext": "Klamroth R, Windyga J, Radulescu V, et al. Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: results from the phase 3 PROPEL study. Blood. 2021; 137 (13): 1818\u20131827. doi: 10.1182/blood.2020005673",
                        "@reference-instance-id": "OB2BibRecID-950575767-c4a38d2d07617ec44792c3b0e3b9d363-31",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: results from the phase 3 PROPEL study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood.2020005673",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0031",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85103595327",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "137",
                                    "@issue": "13"
                                },
                                "pagerange": {
                                    "@first": "1818",
                                    "@last": "1827"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Klamroth",
                                        "ce:indexed-name": "Klamroth R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Windyga",
                                        "ce:indexed-name": "Windyga J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Radulescu",
                                        "ce:indexed-name": "Radulescu V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Klamroth R, Windyga J, Radulescu V, et al. Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: results from the phase 3 PROPEL study. Blood. 2021; 137 (13): 1818\u20131827. doi: 10.1182/blood.2020005673"
                    },
                    {
                        "ref-fulltext": "Mullins ES, Stasyshyn O, Alvarez-Roman MT, et al. Extended half-life pegylated, full-length recombinant factor VIII for prophylaxis in children with severe haemophilia A. Haemophilia. 2017; 23 (2): 238\u2013246. doi: 10.1111/hae.13119",
                        "@reference-instance-id": "OB2BibRecID-950575767-d732bac7d4f05a60e5311cdcf0ead6fe-32",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Extended half-life pegylated, full-length recombinant factor VIII for prophylaxis in children with severe haemophilia A"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/hae.13119",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0032",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85005848070",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "23",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "238",
                                    "@last": "246"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Mullins",
                                        "ce:indexed-name": "Mullins E.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "O.",
                                        "@_fa": "true",
                                        "ce:surname": "Stasyshyn",
                                        "ce:indexed-name": "Stasyshyn O."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Alvarez-Roman",
                                        "ce:indexed-name": "Alvarez-Roman M.T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Haemophilia"
                        },
                        "ce:source-text": "Mullins ES, Stasyshyn O, Alvarez-Roman MT, et al. Extended half-life pegylated, full-length recombinant factor VIII for prophylaxis in children with severe haemophilia A. Haemophilia. 2017; 23 (2): 238\u2013246. doi: 10.1111/hae.13119"
                    },
                    {
                        "ref-fulltext": "Konkle BA, Stasyshyn O, Chowdary P, et al. Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A. Blood. 2015; 126 (9): 1078\u20131085. doi: 10.1182/blood-2015-03-630897",
                        "@reference-instance-id": "OB2BibRecID-950575767-52b857df4185ea08cfb59d7b72b16df9-33",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2015-03-630897",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0033",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84942546645",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "126",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1078",
                                    "@last": "1085"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Konkle",
                                        "ce:indexed-name": "Konkle B.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "O.",
                                        "@_fa": "true",
                                        "ce:surname": "Stasyshyn",
                                        "ce:indexed-name": "Stasyshyn O."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Chowdary",
                                        "ce:indexed-name": "Chowdary P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Konkle BA, Stasyshyn O, Chowdary P, et al. Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A. Blood. 2015; 126 (9): 1078\u20131085. doi: 10.1182/blood-2015-03-630897"
                    },
                    {
                        "ref-fulltext": "Miller CH, Benson J, Ellingsen D, et al. F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity. Haemophilia. 2012; 18 (3): 375\u2013382. doi: 10.1111/j.1365-2516.2011.02700.x",
                        "@reference-instance-id": "OB2BibRecID-950575767-790d7aa032a19affcbd2692955dabb1b-34",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/j.1365-2516.2011.02700.x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0034",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84860334450",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "18",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "375",
                                    "@last": "382"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Miller",
                                        "ce:indexed-name": "Miller C.H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Benson",
                                        "ce:indexed-name": "Benson J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Ellingsen",
                                        "ce:indexed-name": "Ellingsen D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Haemophilia"
                        },
                        "ce:source-text": "Miller CH, Benson J, Ellingsen D, et al. F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity. Haemophilia. 2012; 18 (3): 375\u2013382. doi: 10.1111/j.1365-2516.2011.02700.x"
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Durham",
            "@id": "60112142",
            "affilname": "IQVIA Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60112142",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": null,
            "@id": "60103837",
            "affilname": "Hospital Pulau Pinang",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103837",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Adana",
            "@id": "60087899",
            "affilname": "T.C. Sağlık Bakanliği Adana Numune Eğitim ve Araştirma Hastanesine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60087899",
            "affiliation-country": "Turkey"
        },
        {
            "affiliation-city": "Kyiv",
            "@id": "60068515",
            "affilname": "National Academy of Medical Sciences of Ukraine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068515",
            "affiliation-country": "Ukraine"
        },
        {
            "affiliation-city": "Milan",
            "@id": "60030318",
            "affilname": "Università degli Studi di Milano",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030318",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Chicago IL",
            "@id": "60017031",
            "affilname": "Ann &amp; Robert H. Lurie Children's Hospital of Chicago",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017031",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Milan",
            "@id": "60007067",
            "affilname": "Ospedale Maggiore Policlinico Milano",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007067",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Atlanta",
            "@id": "60000928",
            "affilname": "Emory University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000928",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Cambridge",
            "@id": "127686493",
            "affilname": "Inc",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/127686493",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Vienna",
            "@id": "123341180",
            "affilname": "Takeda Company",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/123341180",
            "affiliation-country": "Austria"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85169881680",
        "dc:description": "Aim: To determine the immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients (PUPs) with severe hemophilia A (HA). Methods: This prospective, phase 3 study (NCT02615691) was conducted in PUPs, or patients with ≤2 exposure days (EDs) prior to screening, aged <6 years with severe HA. The primary endpoint was incidence of factor VIII (FVIII) inhibitor development. This protocol-specified interim analysis was conducted after 50 patients had completed ≥50 EDs without developing FVIII inhibitors or had developed a confirmed inhibitor at any time. Results: Of the enrolled patients, 59/80 (73.8%) received ≥1 dose of rurioctocog alfa pegol; 54 received prophylaxis, and 35 on-demand treatment. Incidence of inhibitor development was 0.19 (10/52). Total annualized bleeding rate (95% CIs) was 3.2 (2.0\u20135.0) for patients receiving prophylaxis and 3.2 (1.6\u20136.3) for on-demand treatment. Hemostatic efficacy of most bleedings was rated as \u2018excellent\u2019 or \u2018good\u2019 after 24 hours (122/131 [93.1%]) and at resolution (161/170 [94.7%]). Five patients received ≥1 dose of rurioctocog alfa pegol for immune tolerance induction (ITI) and 1 patient was defined as having ITI success. Thirteen patients experienced 14 treatment-related adverse events, including 10 cases of FVIII inhibitor development. Conclusion: This is the first prospective study of rurioctocog alfa pegol for the treatment of PUPs with severe HA. Trial Registration: This trial is registered at ClinicalTrials.gov (CT.gov identifier: NCT02615691).",
        "pubmed-id": "37646148",
        "prism:coverDate": "2023-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85169881680",
        "subtypeDescription": "Article",
        "dc:creator": {"author": [{
            "ce:given-name": "Robert F.",
            "preferred-name": {
                "ce:given-name": "Robert F.",
                "ce:initials": "R.F.",
                "ce:surname": "Sidonio",
                "ce:indexed-name": "Sidonio R.F."
            },
            "@seq": "1",
            "ce:initials": "R.F.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60000928",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000928"
            },
            "ce:surname": "Sidonio",
            "@auid": "6505569713",
            "ce:suffix": "Jr.",
            "author-url": "https://api.elsevier.com/content/author/author_id/6505569713",
            "ce:indexed-name": "Sidonio R.F."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85169881680"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85169881680&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85169881680&origin=inward"
            }
        ],
        "prism:publicationName": "Expert Review of Hematology",
        "source-id": "19700174994",
        "citedby-count": "0",
        "subtype": "ar",
        "dc:title": "Immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A: interim results from a phase 3, prospective, multicenter, open-label study",
        "openaccess": "1",
        "openaccessFlag": "true",
        "prism:doi": "10.1080/17474086.2023.2247160",
        "prism:issn": "17474094 17474086",
        "publishercopyright": "© 2023 TakedaDevelopment Center Americas, Inc. Published by Informa UK Limited, trading as Taylor & Francis Group.",
        "dc:identifier": "SCOPUS_ID:85169881680",
        "dc:publisher": "Taylor and Francis Ltd."
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Antibodies"
        },
        {
            "@_fa": "true",
            "$": "factor VIII"
        },
        {
            "@_fa": "true",
            "$": "hemophilia A"
        },
        {
            "@_fa": "true",
            "$": "inhibitors"
        },
        {
            "@_fa": "true",
            "$": "prophylaxis"
        },
        {
            "@_fa": "true",
            "$": "safety"
        }
    ]},
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Hematology",
        "@code": "2720",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Robert F.",
            "preferred-name": {
                "ce:given-name": "Robert F.",
                "ce:initials": "R.F.",
                "ce:surname": "Sidonio",
                "ce:indexed-name": "Sidonio R.F."
            },
            "@seq": "1",
            "ce:initials": "R.F.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60000928",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000928"
            },
            "ce:surname": "Sidonio",
            "@auid": "6505569713",
            "ce:suffix": "Jr.",
            "author-url": "https://api.elsevier.com/content/author/author_id/6505569713",
            "ce:indexed-name": "Sidonio R.F."
        },
        {
            "ce:given-name": "Alexis A.",
            "preferred-name": {
                "ce:given-name": "Alexis A.",
                "ce:initials": "A.A.",
                "ce:surname": "Thompson",
                "ce:indexed-name": "Thompson A.A."
            },
            "@seq": "2",
            "ce:initials": "A.A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60017031",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017031"
            },
            "ce:surname": "Thompson",
            "@auid": "7404597483",
            "author-url": "https://api.elsevier.com/content/author/author_id/7404597483",
            "ce:indexed-name": "Thompson A.A."
        },
        {
            "ce:given-name": "Flora",
            "preferred-name": {
                "ce:given-name": "Flora",
                "ce:initials": "F.",
                "ce:surname": "Peyvandi",
                "ce:indexed-name": "Peyvandi F."
            },
            "@seq": "3",
            "ce:initials": "F.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60007067",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007067"
                },
                {
                    "@id": "60030318",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030318"
                }
            ],
            "ce:surname": "Peyvandi",
            "@auid": "57211730916",
            "author-url": "https://api.elsevier.com/content/author/author_id/57211730916",
            "ce:indexed-name": "Peyvandi F."
        },
        {
            "ce:given-name": "Oleksandra",
            "preferred-name": {
                "ce:given-name": "Oleksandra",
                "ce:initials": "O.",
                "ce:surname": "Stasyshyn",
                "ce:indexed-name": "Stasyshyn O."
            },
            "@seq": "4",
            "ce:initials": "O.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60068515",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068515"
            },
            "ce:surname": "Stasyshyn",
            "@auid": "55786651500",
            "author-url": "https://api.elsevier.com/content/author/author_id/55786651500",
            "ce:indexed-name": "Stasyshyn O."
        },
        {
            "ce:given-name": "Seoh Leng",
            "preferred-name": {
                "ce:given-name": "Seoh Leng",
                "ce:initials": "S.L.",
                "ce:surname": "Yeoh",
                "ce:indexed-name": "Yeoh S.L."
            },
            "@seq": "5",
            "ce:initials": "S.L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60103837",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103837"
            },
            "ce:surname": "Yeoh",
            "@auid": "58563992400",
            "author-url": "https://api.elsevier.com/content/author/author_id/58563992400",
            "ce:indexed-name": "Yeoh S.L."
        },
        {
            "ce:given-name": "Darintr",
            "preferred-name": {
                "ce:given-name": "Darintr",
                "ce:initials": "D.",
                "ce:surname": "Sosothikul",
                "ce:indexed-name": "Sosothikul D."
            },
            "@seq": "6",
            "ce:initials": "D.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                },
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                }
            ],
            "ce:surname": "Sosothikul",
            "@auid": "15830686100",
            "author-url": "https://api.elsevier.com/content/author/author_id/15830686100",
            "ce:indexed-name": "Sosothikul D."
        },
        {
            "ce:given-name": "Ali Bulent",
            "preferred-name": {
                "ce:given-name": "Ali Bulent",
                "ce:initials": "A.B.",
                "ce:surname": "Antmen",
                "ce:indexed-name": "Antmen A.B."
            },
            "@seq": "7",
            "ce:initials": "A.B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60087899",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60087899"
            },
            "ce:surname": "Antmen",
            "@auid": "57210409659",
            "author-url": "https://api.elsevier.com/content/author/author_id/57210409659",
            "ce:indexed-name": "Antmen A.B."
        },
        {
            "ce:given-name": "Caterina",
            "preferred-name": {
                "ce:given-name": "Caterina",
                "ce:initials": "C.",
                "ce:surname": "Maggiore",
                "ce:indexed-name": "Maggiore C."
            },
            "@seq": "8",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60112142",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60112142"
            },
            "ce:surname": "Maggiore",
            "@auid": "57196472137",
            "author-url": "https://api.elsevier.com/content/author/author_id/57196472137",
            "ce:indexed-name": "Maggiore C."
        },
        {
            "ce:given-name": "Werner",
            "preferred-name": {
                "ce:given-name": "Werner",
                "ce:initials": "W.",
                "ce:surname": "Engl",
                "ce:indexed-name": "Engl W."
            },
            "@seq": "9",
            "ce:initials": "W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "123341180",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/123341180"
            },
            "ce:surname": "Engl",
            "@auid": "13102650700",
            "author-url": "https://api.elsevier.com/content/author/author_id/13102650700",
            "ce:indexed-name": "Engl W."
        },
        {
            "ce:given-name": "Bruce",
            "preferred-name": {
                "ce:given-name": "Bruce",
                "ce:initials": "B.",
                "ce:surname": "Ewenstein",
                "ce:indexed-name": "Ewenstein B."
            },
            "@seq": "10",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "127686493",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/127686493"
            },
            "ce:surname": "Ewenstein",
            "@auid": "57209646919",
            "author-url": "https://api.elsevier.com/content/author/author_id/57209646919",
            "ce:indexed-name": "Ewenstein B."
        },
        {
            "ce:given-name": "Srilatha",
            "preferred-name": {
                "ce:given-name": "Srilatha",
                "ce:initials": "S.",
                "ce:surname": "Tangada",
                "ce:indexed-name": "Tangada S."
            },
            "@seq": "11",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "127686493",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/127686493"
            },
            "ce:surname": "Tangada",
            "@auid": "6506136597",
            "author-url": "https://api.elsevier.com/content/author/author_id/6506136597",
            "ce:indexed-name": "Tangada S."
        }
    ]}
}}